Current early diagnostic biomarkers of prostate cancer

Prostate cancer (PCa) has become to have the highest incidence and the second mortality rate in western countries, affecting men's health to a large extent. Although prostate-specific antigen (PSA) was discovered to help diagnose the cancer in an early stage for decades, its specificity is rela...

Full description

Bibliographic Details
Main Authors: Min Qu, Shan-Cheng Ren, Ying-Hao Sun
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-08-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=549;epage=554;aulast=Qu
_version_ 1828258834267766784
author Min Qu
Shan-Cheng Ren
Ying-Hao Sun
author_facet Min Qu
Shan-Cheng Ren
Ying-Hao Sun
author_sort Min Qu
collection DOAJ
description Prostate cancer (PCa) has become to have the highest incidence and the second mortality rate in western countries, affecting men's health to a large extent. Although prostate-specific antigen (PSA) was discovered to help diagnose the cancer in an early stage for decades, its specificity is relative low, resulting in unnecessary biopsy for healthy people and over-treatment for patients. Thus, it is imperative to identify more and more effective biomarkers for early diagnosis of PCa in order to distinguish patients from healthy populations, which helps guide an early treatment to lower disease-related mortality by noninvasive or minimal invasive approaches. This review generally describes the current early diagnostic biomarkers of PCa in addition to PSA and summarizes the advantages and disadvantages of these biomarkers.
first_indexed 2024-04-13T02:59:21Z
format Article
id doaj.art-0a367adc6a2c43db9fa0c3663040b291
institution Directory Open Access Journal
issn 1008-682X
1745-7262
language English
last_indexed 2024-04-13T02:59:21Z
publishDate 2014-08-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Andrology
spelling doaj.art-0a367adc6a2c43db9fa0c3663040b2912022-12-22T03:05:30ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622014-08-0116454955410.4103/1008-682X.129211Current early diagnostic biomarkers of prostate cancerMin QuShan-Cheng RenYing-Hao SunProstate cancer (PCa) has become to have the highest incidence and the second mortality rate in western countries, affecting men's health to a large extent. Although prostate-specific antigen (PSA) was discovered to help diagnose the cancer in an early stage for decades, its specificity is relative low, resulting in unnecessary biopsy for healthy people and over-treatment for patients. Thus, it is imperative to identify more and more effective biomarkers for early diagnosis of PCa in order to distinguish patients from healthy populations, which helps guide an early treatment to lower disease-related mortality by noninvasive or minimal invasive approaches. This review generally describes the current early diagnostic biomarkers of PCa in addition to PSA and summarizes the advantages and disadvantages of these biomarkers.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=549;epage=554;aulast=Quearly diagnostic biomarkers; MALAT1-derived miniRNA; PCA3; prostate cancer; PSA
spellingShingle Min Qu
Shan-Cheng Ren
Ying-Hao Sun
Current early diagnostic biomarkers of prostate cancer
Asian Journal of Andrology
early diagnostic biomarkers; MALAT1-derived miniRNA; PCA3; prostate cancer; PSA
title Current early diagnostic biomarkers of prostate cancer
title_full Current early diagnostic biomarkers of prostate cancer
title_fullStr Current early diagnostic biomarkers of prostate cancer
title_full_unstemmed Current early diagnostic biomarkers of prostate cancer
title_short Current early diagnostic biomarkers of prostate cancer
title_sort current early diagnostic biomarkers of prostate cancer
topic early diagnostic biomarkers; MALAT1-derived miniRNA; PCA3; prostate cancer; PSA
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=549;epage=554;aulast=Qu
work_keys_str_mv AT minqu currentearlydiagnosticbiomarkersofprostatecancer
AT shanchengren currentearlydiagnosticbiomarkersofprostatecancer
AT yinghaosun currentearlydiagnosticbiomarkersofprostatecancer